Aaron de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Aaron de Souza has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Rainha J. de Souza
NeuroCare, Pereira Plaza, Margao, Goa, 403 601, India
5 shared publicationsParesh K. Desai
Apollo Victor Hospital, Malbhat, Margao, Goa 403 601, India
4 shared publicationsG. Yeshraj
Departments of Neurology, National Institute of Mental Health and Neurosciences; Bangalore, India
3 shared publicationsK. Thennarasu
Biostatistics, National Institute of Mental Health and Neurosciences; Bangalore, India
3 shared publicationsKandavel Thennarasu
Department of Biostatistics, National Institute of Mental Health and Neurosciences, Bangalore 560 029, India
3 shared publications- Siddalingaiah H. S.
Shridevi Institute of Medical Sciences and Research Hospital
3 shared publications
Latest Publications
- 21 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1774-1775
Isolated Segmental Face and Neck Myoclonus Associated with Ceftriaxone
- 21 January 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (7) , 1774-1775
Isolated Segmental Face and Neck Myoclonus Associated with Ceftriaxone
- 8 December 2025
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (2) , 683-685
Lumbosacral plexopathy due to aggressive granulomatosis from hip arthroplasty
- 8 December 2025
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (2) , 683-685
Lumbosacral plexopathy due to aggressive granulomatosis from hip arthroplasty
- 4 October 2024
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-4
Hemidystonia-hemiatrophy syndrome following placement of internal carotid artery flow diverter stent
We report hemidystonia and cerebral hemiatrophy in a 39-year old woman beginning three months after placement of an internal carotid artery flow diverting stent for supraclinoid aneurysm, complicated by early post-procedural stroke. We highlight the unusual demographics and short latency to onset, as well as the occurrence of striatal mineralisation, which may reflect ongoing neurodegeneration, but has also been suggested to contribute to oxidative neuronal injury. The late age of the inciting cerebral insult and of onset of the movement disorder, temporal course, and relation to endovascular intervention serve to expand the spectrum of this unusual condition.
- 4 October 2024
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-4
Hemidystonia-hemiatrophy syndrome following placement of internal carotid artery flow diverter stent
We report hemidystonia and cerebral hemiatrophy in a 39-year old woman beginning three months after placement of an internal carotid artery flow diverting stent for supraclinoid aneurysm, complicated by early post-procedural stroke. We highlight the unusual demographics and short latency to onset, as well as the occurrence of striatal mineralisation, which may reflect ongoing neurodegeneration, but has also been suggested to contribute to oxidative neuronal injury. The late age of the inciting cerebral insult and of onset of the movement disorder, temporal course, and relation to endovascular intervention serve to expand the spectrum of this unusual condition.
- Open Access
- 12 February 2024
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 52 (1) , 162-163
Idiopathic Extracranial Internal Carotid Artery Vasospasm
- 12 February 2024
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 52 (1) , 162-163
Open AccessIdiopathic Extracranial Internal Carotid Artery Vasospasm
- Open Access
- 29 January 2024
- Published by Wiley in Case Reports in Transplantation
- Vol. 2024, 1-3
De Novo Onset of Myasthenia Gravis after Kidney Transplantation
Myasthenia gravis occurring de novo after kidney transplantation is a rare course of severe muscle weakness. A 57-year-old female on treatment with peritoneal dialysis following polycystic kidney disease received a renal transplant with standard basiliximab induction. She had no preceding history of neuromuscular problems. Three months after transplant she presented with progressive weakness and fatigability, finally needing a wheelchair to mobilise. Graft function was stable. Examination revealed patchy limb weakness, worsening on repeated exercise. There were no abnormalities in cranial nerves, reflexes, or sensation. Electromyography was normal, but repetitive nerve stimulation studies showed a postsynaptic neuromuscular transmission defect suggestive of myasthenia gravis. Serological testing revealed no putative antibodies. Initial treatment with pyridostigmine was not tolerated. Following an episode of hospitalisation with severe limb weakness, she received intravenous immunoglobulin and showed dramatic improvement, which persisted over the next few weeks. Approximately 6 months later, she had a relapse of her symptoms, which once again responded to intravenous immunoglobulin therapy. De novo myasthenia gravis after transplantation is a rare entity, infrequently reported in the literature. This illness is surprising since immunosuppression after transplant is usually sufficient to prevent immune-mediated disease. This patient had no history of similar illnesses. Delayed physical recovery after major surgery such as renal transplantation is often attributed to other causes such as deconditioning, and patients are often prescribed physiotherapy as a response. In this patient, the profound unexplained weakness that persisted for several weeks after transplant prompted referral to the neurologist, which enabled this rare diagnosis to be made. This story highlights the need to monitor unexpected symptoms closely and to consider a wide differential diagnosis when improvement after transplant is not along usual expected lines. Finally, this case also illustrates the benefits of multidisciplinary involvement in the care of these complex patients.
- 29 January 2024
- Published by Wiley in Case Reports in Transplantation
- Vol. 2024, 1-3
Open AccessDe Novo Onset of Myasthenia Gravis after Kidney Transplantation
Myasthenia gravis occurring de novo after kidney transplantation is a rare course of severe muscle weakness. A 57-year-old female on treatment with peritoneal dialysis following polycystic kidney disease received a renal transplant with standard basiliximab induction. She had no preceding history of neuromuscular problems. Three months after transplant she presented with progressive weakness and fatigability, finally needing a wheelchair to mobilise. Graft function was stable. Examination revealed patchy limb weakness, worsening on repeated exercise. There were no abnormalities in cranial nerves, reflexes, or sensation. Electromyography was normal, but repetitive nerve stimulation studies showed a postsynaptic neuromuscular transmission defect suggestive of myasthenia gravis. Serological testing revealed no putative antibodies. Initial treatment with pyridostigmine was not tolerated. Following an episode of hospitalisation with severe limb weakness, she received intravenous immunoglobulin and showed dramatic improvement, which persisted over the next few weeks. Approximately 6 months later, she had a relapse of her symptoms, which once again responded to intravenous immunoglobulin therapy. De novo myasthenia gravis after transplantation is a rare entity, infrequently reported in the literature. This illness is surprising since immunosuppression after transplant is usually sufficient to prevent immune-mediated disease. This patient had no history of similar illnesses. Delayed physical recovery after major surgery such as renal transplantation is often attributed to other causes such as deconditioning, and patients are often prescribed physiotherapy as a response. In this patient, the profound unexplained weakness that persisted for several weeks after transplant prompted referral to the neurologist, which enabled this rare diagnosis to be made. This story highlights the need to monitor unexpected symptoms closely and to consider a wide differential diagnosis when improvement after transplant is not along usual expected lines. Finally, this case also illustrates the benefits of multidisciplinary involvement in the care of these complex patients.
- Open Access
- 19 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (4) , 1741-1748
Dural arteriovenous fistula presenting with recurrent focal status epilepticus and lateralised periodic epileptiform discharges
Background: Dural arteriovenous fistulae (dAVF) are relatively infrequently encountered, and status epilepticus (SE) and lateralised periodic discharges (LPDs) on electroencephalography (EEG) have only rarely been associated with these arteriovenous malformations. Methods: We present a patient with recurrent presentations with focal SE, aphasia and other focal deficits of cortical function and ictal and peri-ictal LPDs on serial EEG, who was shown to have a left hemispheric dAVF associated with left transverse and sigmoid sinus thrombosis. Seizures proved refractory to four anti-seizure medications but became more amenable to control after successful embolisation of the dAVF, with subsequent resolution of the focal cortical deficits. We discuss the co-occurrence of SE and LPDs with dAVF and review previously reported cases with this rare association. Conclusions: Our report supports a causative relationship between dAVF and focal SE, manifesting as ictal LPDs on EEG, and highlights the importance of active dAVF management in achieving seizure control. The relatively good patient outcome contrasts to the few similar case reports. Whilst rare, it is important to consider dAVF as a potentially treatable condition underlying new-onset seizures, including SE.
- 19 January 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (4) , 1741-1748
Open AccessDural arteriovenous fistula presenting with recurrent focal status epilepticus and lateralised periodic epileptiform discharges
Background: Dural arteriovenous fistulae (dAVF) are relatively infrequently encountered, and status epilepticus (SE) and lateralised periodic discharges (LPDs) on electroencephalography (EEG) have only rarely been associated with these arteriovenous malformations. Methods: We present a patient with recurrent presentations with focal SE, aphasia and other focal deficits of cortical function and ictal and peri-ictal LPDs on serial EEG, who was shown to have a left hemispheric dAVF associated with left transverse and sigmoid sinus thrombosis. Seizures proved refractory to four anti-seizure medications but became more amenable to control after successful embolisation of the dAVF, with subsequent resolution of the focal cortical deficits. We discuss the co-occurrence of SE and LPDs with dAVF and review previously reported cases with this rare association. Conclusions: Our report supports a causative relationship between dAVF and focal SE, manifesting as ictal LPDs on EEG, and highlights the importance of active dAVF management in achieving seizure control. The relatively good patient outcome contrasts to the few similar case reports. Whilst rare, it is important to consider dAVF as a potentially treatable condition underlying new-onset seizures, including SE.
- 2 December 2023
- Published by BMJ in Practical Neurology
- Vol. 24 (3) , 219-222
Amyotrophic lateral sclerosis with demyelinating neurophysiology and a motor band sign
We describe an unusual case of clinical amyotrophic lateral sclerosis (ALS) with initial neurophysiological studies suggesting demyelination, along with neuroimaging findings that helped to support the eventual diagnosis. An otherwise well 68-year-old man had 8 weeks of left upper limb weakness. On examination, there were widespread lower and upper motor neurone findings suggesting ALS. However, nerve conduction studies identified sensorimotor demyelinating changes suggesting chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a diagnosis further supported by cerebrospinal fluid analysis. MR scan of the brain revealed a ‘motor band’, a feature seen commonly in ALS. His condition was refractory to immunotherapy with clinical progression in-keeping with ALS, establishing the diagnosis. ALS is rarely associated with demyelinating neurophysiological changes resembling CIDP. The clinical phenotype is crucial to support the correct diagnosis and imaging findings may help.
- 2 December 2023
- Published by BMJ in Practical Neurology
- Vol. 24 (3) , 219-222
Amyotrophic lateral sclerosis with demyelinating neurophysiology and a motor band sign
We describe an unusual case of clinical amyotrophic lateral sclerosis (ALS) with initial neurophysiological studies suggesting demyelination, along with neuroimaging findings that helped to support the eventual diagnosis. An otherwise well 68-year-old man had 8 weeks of left upper limb weakness. On examination, there were widespread lower and upper motor neurone findings suggesting ALS. However, nerve conduction studies identified sensorimotor demyelinating changes suggesting chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a diagnosis further supported by cerebrospinal fluid analysis. MR scan of the brain revealed a ‘motor band’, a feature seen commonly in ALS. His condition was refractory to immunotherapy with clinical progression in-keeping with ALS, establishing the diagnosis. ALS is rarely associated with demyelinating neurophysiological changes resembling CIDP. The clinical phenotype is crucial to support the correct diagnosis and imaging findings may help.
- Open Access
- 27 October 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 51 (5) , 681-682
“Hummingbird Sign” Associated with Obstructive Hydrocephalus Due to Aqueductal Web
- 27 October 2023
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 51 (5) , 681-682
Open Access“Hummingbird Sign” Associated with Obstructive Hydrocephalus Due to Aqueductal Web
- Open Access
- 31 August 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (12) , 4519-4524
Multifocal neuropathy and Horner’s syndrome due to disseminated pyomyositis in an intravenous drug user
Background: The formation of abscesses with necrosis within large, striated muscles leads to pyomyositis, a condition relatively rarely encountered outside the tropics. Intravenous drug users and other immunocompromised individuals are predisposed toward this infection, which may occur due to local or haematogenous spread of infection to skeletal muscles previously damaged by trauma, exercise, or rhabdomyolysis. Methods: We report a young male intravenous drug user with rhabdomyolysis due to use of a synthetic opioid, in whom disseminated pyomyositis was detected following evaluation for sciatic and radial neuropathies and Horner’s syndrome and review available reports of peripheral nerve dysfunction in the setting of this uncommon infection. We searched online databases to identify all published reports on adult patients with pyomyositis complicated by peripheral nerve dysfunction. Conclusions: Peripheral nerve dysfunction may rarely occur via local spread of infection or compression from abscesses.
- 31 August 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (12) , 4519-4524
Open AccessMultifocal neuropathy and Horner’s syndrome due to disseminated pyomyositis in an intravenous drug user
Background: The formation of abscesses with necrosis within large, striated muscles leads to pyomyositis, a condition relatively rarely encountered outside the tropics. Intravenous drug users and other immunocompromised individuals are predisposed toward this infection, which may occur due to local or haematogenous spread of infection to skeletal muscles previously damaged by trauma, exercise, or rhabdomyolysis. Methods: We report a young male intravenous drug user with rhabdomyolysis due to use of a synthetic opioid, in whom disseminated pyomyositis was detected following evaluation for sciatic and radial neuropathies and Horner’s syndrome and review available reports of peripheral nerve dysfunction in the setting of this uncommon infection. We searched online databases to identify all published reports on adult patients with pyomyositis complicated by peripheral nerve dysfunction. Conclusions: Peripheral nerve dysfunction may rarely occur via local spread of infection or compression from abscesses.